Milestone Pharmaceuticals Inc. (MIST) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 192.25M | 111.92M | 86.67M | 46.17M | 60.48M | 73.93M | 80.99M | 87.36M | 93.97M | 73.03M | 84.8M | 94.57M |
| Cash & Short-Term Investments | 184.22M | 105.96M | 82.58M | 43.42M | 55.96M | 69.69M | 76.42M | 83.25M | 89.48M | 66M | 75.75M | 87.59M |
| Cash Only | 71.32M | 73.05M | 46.69M | 42.5M | 45.09M | 25.31M | 12.8M | 13.26M | 10.13M | 13.76M | 9.88M | 32.59M |
| Short-Term Investments | 112.9M | 32.91M | 35.9M | 918K | 10.87M | 44.38M | 63.62M | 69.99M | 79.35M | 52.24M | 65.87M | 55M |
| Accounts Receivable | 5M | 3.51M | 1.51M | 2M | 2.16M | 2.39M | 2.05M | 2.39M | 2.12M | 3.85M | 0 | 0 |
| Days Sales Outstanding | 1.61K | 149.25 | - | - | - | - | - | - | - | - | - | - |
| Inventory | 1.83M | 648K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | 1.59K | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.09M | 1.57M |
| Total Non-Current Assets | 1.48M | 1.64M | 1.08M | 1.25M | 1.41M | 1.57M | 1.72M | 1.87M | 2.03M | 2.19M | 2.32M | 2.45M |
| Property, Plant & Equipment | 1.48M | 1.64M | 1.08M | 1.25M | 1.41M | 1.57M | 1.72M | 1.87M | 2.03M | 2.19M | 2.32M | 2.45M |
| Fixed Asset Turnover | 0.15x | 1.14x | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 193.73M | 113.56M | 87.75M | 47.42M | 61.88M | 75.5M | 82.71M | 89.23M | 96M | 75.23M | 87.12M | 97.02M |
| Asset Turnover | 0.00x | 0.02x | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 213.05% | 50.41% | 6.1% | -46.86% | -35.54% | 0.36% | -5.06% | -8.03% | -13.57% | 1% | 1.57% | 6.27% |
| Total Current Liabilities | 20.94M | 13.98M | 10.52M | 9.28M | 12.96M | 8.13M | 5.26M | 4.57M | 4.13M | 7.23M | 8.11M | 6.81M |
| Accounts Payable | 10.02M | 5.64M | 3.18M | 2.93M | 2.38M | 1.93M | 1.63M | 749K | 1.73M | 3.98M | 1.85M | 2.4M |
| Days Payables Outstanding | 10.07K | - | 11.24K | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 659K | 647K | 483K | 515K | 0 | 0 | 0 | 567K | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 416K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 8.69M | 7.69M | 4.45M | 3.81M | 1.16M | 0 | 0 | 1.83M | 824K | 1.99M | 0 | 0 |
| Current Ratio | 9.18x | 8.01x | 8.24x | 4.97x | 4.67x | 9.10x | 15.40x | 19.13x | 22.75x | 10.11x | 10.45x | 13.89x |
| Quick Ratio | 9.09x | 7.96x | 8.24x | 4.97x | 4.67x | 9.10x | 15.40x | 19.13x | 22.75x | 10.11x | 10.45x | 13.89x |
| Cash Conversion Cycle | -6.87K | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 136.74M | 57.81M | 56.72M | 55.88M | 55.05M | 54.23M | 53.44M | 52.69M | 51.95M | 51.23M | 50.5M | 49.8M |
| Long-Term Debt | 136.3M | 57.19M | 56.21M | 55.24M | 54.29M | 53.35M | 52.43M | 51.53M | 50.64M | 49.77M | 48.91M | 48.07M |
| Capital Lease Obligations | 366K | 539K | 519K | 641K | 758K | 874K | 1M | 1.16M | 1.31M | 1.46M | 1.58M | 1.73M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 72K | 83K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 157.69M | 71.79M | 67.25M | 65.16M | 68.01M | 62.35M | 58.69M | 57.25M | 56.08M | 58.45M | 58.61M | 56.61M |
| Total Debt | 137.33M | 58.38M | 57.21M | 56.39M | 55.59M | 54.8M | 54.02M | 53.25M | 52.51M | 51.77M | 51.03M | 50.32M |
| Net Debt | 66.01M | -14.67M | 10.52M | 13.89M | 10.5M | 29.48M | 41.22M | 39.99M | 42.37M | 38.02M | 41.15M | 17.73M |
| Debt / Equity | 3.81x | 1.40x | 2.79x | - | - | 4.17x | 2.25x | 1.67x | 1.32x | 3.09x | 1.79x | 1.25x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -5.75x | -16.67x | -11.40x | -12.63x | -21.20x | -12.45x | -9.45x | -9.56x | -10.87x | -14.88x | -16.93x | -18.56x |
| Total Equity | 36.05M | 41.77M | 20.5M | -17.75M | -6.12M | 13.15M | 24.01M | 31.98M | 39.92M | 16.77M | 28.5M | 40.41M |
| Equity Growth % | 688.75% | 217.71% | -14.62% | -155.49% | -115.34% | -21.61% | -15.76% | -20.86% | -25.98% | -74.72% | -63.06% | -53.37% |
| Book Value per Share | 0.28 | 0.50 | 0.31 | -0.27 | -0.09 | 0.21 | 0.36 | 0.48 | 0.80 | 0.50 | 0.66 | 0.94 |
| Total Shareholders' Equity | 36.05M | 41.77M | 20.5M | -17.75M | -6.12M | 13.15M | 24.01M | 31.98M | 39.92M | 16.77M | 28.5M | 40.41M |
| Common Stock | 373.7M | 352.62M | 311.78M | 288.26M | 288.19M | 288.05M | 288.01M | 287.93M | 287.88M | 260.5M | 260.5M | 260.17M |
| Retained Earnings | -456.67M | -430.6M | -413.19M | -401.27M | -388.31M | -367.55M | -355.18M | -345.74M | -336.38M | -326.03M | -312.42M | -297.33M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 55.65M | 55.65M | 55.65M | 53.08M | 53.08M | 53.08M | 53.08M | 53.08M | 53.08M | 48.46M | 48.46M | 48.46M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |